Clinical Trial

A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD

Name: A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD — clinical trial record (NCT07756255)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FMT-ADHD-2026

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The primary goals of this phase 2 clinical trial are to determine the feasibility, safety, and tolerability of oral Fecal Microbiota Transplantation (FMT) in adolescents (aged 13-17) with Attention-Deficit/Hyperactivity Disorder (ADHD).

Trial Details

NCT Number	NCT07756255
Lead Sponsor	University of Calgary Collaborators: Hotchkiss Brain Institute, University of Calgary, Alberta Children's Hospital
Conditions	ADHD, ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type
Enrollment	64 participants
Start Date	2026-08-31
Primary Completion	2028-08-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-10